Unusual picture of an insulinoma in type 2 diabetes mellitus with severe obesity;Ungewohnliches bild eines insulinoms bei diabetes mellitus typ 2 und morbider adipositas

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 9, 1999, Pages 248-252

  Wildbrett, Jan ^a   Nagel, Michael ^a   Theissig, F ^a   Gaertner, H J ^a   Gromeier, Sabine ^a   Fischer, Sabine ^a   Hanefeld, Markolf ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERINSULINISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULINOMA; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; WEIGHT GAIN; GLUCOSE TOLERANCE TEST; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PANCREAS; PANCREAS RESECTION; PANCREAS TUMOR; PATHOLOGY; REVIEW; STATISTICS;

COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULINOMA; MIDDLE AGED; OBESITY, MORBID; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS;

EID: 0033525275     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024280     Document Type: Article

References (24)

1. Bar, R. S., P. Gordon, J. Roth, C. N. Siebert: Insulin receptors in patients with insulinomas: Changes in receptor affinity and concentration. J. Clin. Endocrinol. Metabol. 44 (1977), 1210-1213.
2. Boden, G.: Role of fatty acids in the pathogenase of insulin resistance and NIDDM. Diabetes 46 (1997), 3-10.
3. Boden, G., E. Murer, M. Mozzoli: Glucose transporter proteins in human insulinoma. Ann. Intern. Med. 121 (1994), 109-112.
4. Chung, M. J., B. I. Choi, J. K. Han, J. W. Chung, M. C. Han, S. H. Bae: Functioning islet cell tumor of the pancreas: Localization with dynamic spiral CT. Acta Radiol. 38 (1997), 135-138.
5. DeFronzo, R. A.: The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37 (1988), 667-687.
6. Garvey, W. T., J. M. Olefsky, S. Marshall: Insulin induces progressive insulin resistance in cultured rat adipocytes. Diabetes 35 (1986), 258-267.
7. Inadera, H., S. Ito, Y. Ishikawa, M. Shinomiya, K. Shirai, Y. Saito, S. Yoshida: Visceral fat deposition is seen in patients with insulinoma. Diabetologia 36 (1993), 91-92.
8. Irvin, M., L. H. Tang: Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). Gastroenterology 112 (1997), 583-590.
9. Kane, L. A., C. S. Grant, T. B. Nippoldt, F. J. Service: Insulinoma in a patient with NIDDM. Diabetes Care 16 (1993), 1298-1300.
10. King, C. M. P., R. H. Reznek, J. E. Dacie, J. A. H. Wass: Imaging islet cell tumours. Clin. Radiol. 49 (1994), 295-303.
11. Marks, V.: Tumours producing hypoglycaemia. Diabetes Metab. Rev. 7 (1991), 79-91.
12. Marshall, S., J. M. Olefsky: Effect of insulin incubation on isolated rat adipocytes. Evidence of hormone-induced desensitisation at the receptor and post-receptor level. J. Clin. Invest. 66 (1980), 763-772.
13. Nankervis, A., J. Proietto, P. Aitken, F. Alford: Hyperinsulinemia and insulin insensitivity: Studies in subjects with insulinomas. Diabetologia 28 (1985), 427-431.
14. Perry, R. R., A. I. Vinik: Diagnosis and Management of functioning islet cell tumors: ICEM 80 (1995), 2273-2278.
15. Reaven, G. M.: Role of insulin resistance in human disease. Banting lecture 1988. Diabetes 37 (1988), 1595-1607.
16. Sbraccia, P., M. D. Adamo, F. Leonetti, S. Caiola, P. Iozzo, A. Giaccari, A. Buongiorno, G. Tamburrano: Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma. Diabetologia 39 (1996), 220-225.
17. Seino, Y., T. Yamamoto, K. Inoue, M. Imamura, S. Kadowaki, H. Kojiama, J. Fujikawa: Abnormal facilitative glucose transporter gene expression in human islet cell tumors. J. Clin. Endocrinol. Metab. 76 (1993), 75-78.
18. Service, F. J., A. J. D. Dale, L. R. Elveback, N. S. Jiang: Insulinoma - clinical and diagnostic features of 60 consecutive cases. Mayo Clin. Proc. 51 (1976), 417-429.
19. Service, F. J., M. M. McMahon, P. C. O'Brian, D. J. Ballard: Functioning Insulinoma - incidence, recurrence, a long time survival of patients: a 60 year study. Mayo. Clin. Proc. 66 (1991), 711-719.
20. Sjoberg, R. S., G. S. Kidd: Case report: A glucose responsive insulinoma - implication for the diagnosis of insulin secreting tumors. Amer. J. Med. Sci. 304 (1992), 164-167.
21. Skrha, J., G. Sindelka, T. Haas, J. Hilgertova, V. Justova: Comparison of insulin sensitivity in patients with insulinoma and obese type 2 diabetes mellitus. Horm. Metabol. Res. 28 (1996), 595-598.
22. Svartberg, J., M. Stridsberg, E. Wilander, D. E. H. Andersson, B. Eriksson: Tumor-induced hypoglycaemia in a patient with insulin-dependent diabetes mellitus. J. of Int. Med. 239 (1996), 181-185.
23. Vinik, A. I., N. W. Thompson, S. D. Averbuch: Neoplasma of the gastroenteropancreatic endocrine system. In: Holland, J. F., E. Frei, R. C. Bast, D. W. Kufe, D. L. Morton, R. R. Wechselbaum (Ed.): Cancer Medicine (Lea and Febiger: Philadelphia 1994), 1180-1209.
24. Zilkens, T. M.: Entwicklung eines immunologischen Nachweisverfahrens für Proinsulin (Medizinische Dissertationsschrift: Universität Heidelberg 1994).